| Abstrakt: |
Berberine, an active compound in the extract of golden seal (an age‐long remedy for many infections) has been confirmed to be responsible for the extract's activity against multi‐drug resistant strain of Mycobacterium tuberculosis. There is no available study that shows the exact target of berberine in M tuberculosis, although it is confirmed that berberine inhibits the polymerisation of filamentous temperature‐sensitive mutant Z (FtsZ), an important bacteria cytokinesis protein, in Escherichia coli, suggesting that FtsZ could as well be the target of berberine in M tuberculosis. In this study, we carried out ligand‐based virtual screening to identify analogues of berberine followed by molecular dynamics (MD) simulations of the complexes of Mtb‐FtsZ with berberine (berb1) and the five selected analogues (berb9 [ZINC1709414], berb37 [ZINC238749993], berb38 [ZINC13509022], berb43 [ZINC14765594], and berb48 [ZINC238758595]). Post‐MD analyses such as binding free energy, RMSD, RMSF, RoG and hydrogen bond lifetime analysis were used to understand the interactions between these ligands and the receptor. The results suggested that Mtb‐FtsZ could likely be the target of berberine in M tuberculosis as it forms a stable complex coupled with a significantly high binding energy. The study also identified other potential inhibitors of MTB‐FtsZ polymerisation. Berb38 specifically showed greater interaction with the residues at the binding site of the protein, forming a far more stable complex with the receptor than any of the other compounds under investigation, including berberine itself. ADME properties calculations also predicted all the ligands to be bioactive as orally administered drugs. This study shows that FtsZ could be the target of berberine in Mycobacterium tuberculosis as it forms a stable complex with the protein while also distorting its structural flexibility. In addition, the study Identified other analogues of berberine that could be potential lead compounds for antitubercular drugs through ligand‐based virtual screening, molecular docking, ADME properties prediction and in‐depth post‐molecular dynamics analyses. [ABSTRACT FROM AUTHOR] |
Plný text